Targeting mitochondria in cancer therapy: Insight into photodynamic and photothermal therapies

Area of Science:

• Cell Biology
• Biomedical Engineering
• Oncology

Background:

• Mitochondria are vital organelles regulating cellular energy, reactive oxygen species (ROS), and cell survival.
• Mitophagy, the removal of dysfunctional mitochondria, protects cells under moderate stress but can induce cell death under severe stress.
• Mitochondria play a crucial role in regulated cell death pathways.

Purpose of the Study:

• To review the role of photodynamic (PD) and photothermal (PT) therapies in cancer treatment by targeting mitochondria.
• To explore how these therapies modulate mitochondrial function and induce cancer cell death.
• To summarize recent advancements in mitochondrion-targeting agents and their signaling pathways in cancer therapy.

Main Methods:

• Review of recent scientific literature on PD and PT therapies targeting mitochondria in cancer.
• Analysis of mechanisms by which PD and PT therapies affect mitochondrial membrane potential, respiratory chain, and ROS generation.
• Examination of signaling pathways involved in mitochondrion-mediated cancer cell death.

Main Results:

• PD and PT therapies can effectively target mitochondria, altering their function to promote cancer cell death.
• These therapies leverage the dual role of mitochondria in cell survival and death pathways.
• Targeted mitochondrial therapies show potential for precise tumor erosion and effective cancer treatment.

Conclusions:

• Targeting mitochondria with PD and PT therapies is a promising strategy for cancer treatment.
• Understanding the signaling pathways involved is key to optimizing these mitochondrion-targeting therapies.
• Further research into these targeted therapies could lead to improved cancer treatment outcomes.